Avadel Pharmaceuticals plc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $17.47 on 04/15/24, while the lowest price for the same duration was marked at $9.50 on 10/27/23.
52-week price history of AVDL Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Avadel Pharmaceuticals plc’s current trading price is -2.69% away from its 52-week high, while its distance from the 52-week low is 78.95%. The stock’s price range during the 52-week period has remained between $9.50 and $17.47. In the Healthcare sector, the company’s shares saw a trading volume of around 2.41 million for the day, which was evidently higher than the average daily volume of 1.2 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Avadel Pharmaceuticals plc (AVDL) has experienced a quarterly rise of 14.86% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.62B and boasts a workforce of 154 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 14.60, with a change in price of +6.20. Similarly, Avadel Pharmaceuticals plc recorded 1,094,225 in trading volume during the last 100 days, posting a change of +57.41%.
Examining AVDL’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for AVDL stands at 0.40. Similarly, the long-term debt-to-equity ratio is also 0.39.
AVDL Stock Stochastic Average
As of today, Avadel Pharmaceuticals plc’s raw stochastic average for the last 50 days stands at 83.68%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 63.41%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 42.91% and 38.34%, respectively.
AVDL Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 20.40% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 67.98%. Over the past 30 days, the price of AVDL has fallen by 5.59%. And in the last five days, it has fallen by -0.76%.
